Lot-to-lot variation and verification

被引:1
|
作者
Loh, Tze Ping [1 ,7 ]
Markus, Corey [2 ]
Tan, Chin Hon [3 ]
Tran, Mai Thi Chi [4 ,5 ]
Sethi, Sunil Kumar [1 ]
Lim, Chun Yee [6 ]
机构
[1] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore
[2] Flinders Univ Int Ctr Point of Care Testing, Flinders Hlth & Med Res Inst, Adelaide, SA, Australia
[3] Natl Univ Singapore, Dept Ind & Syst Engn, Singapore, Singapore
[4] Hanoi Med Univ, Fac Med Technol, Hanoi, Vietnam
[5] Natl Childrens Hosp, Dept Clin Biochem, Hanoi, Vietnam
[6] Singapore Inst Technol, Engn Cluster, Singapore, Singapore
[7] Natl Univ Singapore Hosp, Dept Lab Med, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore
关键词
between-reagent lot; bias; drift; imprecision; lot-to-lot variation; lot-to-lot verification; reagent lot; shift; ANALYTICAL PERFORMANCE; CONSENSUS STATEMENT; QUALITY; POOLS;
D O I
10.1515/cclm-2022-1126
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Lot-to-lot verification is an integral component for monitoring the long-term stability of a measurement procedure. The practice is challenged by the resource requirements as well as uncertainty surrounding experimental design and statistical analysis that is optimal for individual laboratories, although guidance is becoming increasingly available. Collaborative verification efforts as well as application of patient-based monitoring are likely to further improve identification of any differences in performance in a relatively timely manner. Appropriate follow up actions of failed lot-to-lot verification is required and must balance potential disruptions to clinical services provided by the laboratory. Manufacturers need to increase transparency surrounding release criteria and work closer with laboratory professionals to ensure acceptable reagent lots are released to end users. A tripartite collaboration between regulatory bodies, manufacturers, and laboratory medicine professional bodies is key to developing a balanced system where regulatory, manufacturing, and clinical requirements of laboratory testing are met, to minimize differences between reagent lots and ensure patient safety. Clinical Chemistry and Laboratory Medicine has served as a fertile platform for advancing the discussion and practice of lot-to-lot verification in the past 60 years and will continue to be an advocate of this important topic for many more years to come.
引用
收藏
页码:769 / 776
页数:8
相关论文
共 50 条
  • [31] Lot-to-Lot Variation in Adeno-Associated Virus Serotype 9 (AAV9) Preparations
    O'Connor, Deirdre M.
    Lutomski, Corinne
    Jarrold, Martin F.
    Boulis, Nicholas M.
    Donsante, Anthony
    HUMAN GENE THERAPY METHODS, 2019, 30 (06) : 214 - 225
  • [32] Investigation of Metformin HCl Lot-to-Lot Variation on Flowability Differences Exhibited during Drug Product Processing
    Vippagunta, Radha R.
    LoBrutto, Rosario
    Pan, Changkang
    Lakshman, Jay P.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (12) : 5030 - 5039
  • [33] Lot-to-lot variation in the microbiota during the brewing process of kimoto-type Japanese rice wine
    Yamane, Momoka
    Sakai, Shuntaro
    Hirai, Miho
    Takayama, Mizuki
    Sasayama, Kohya
    Douchi, Kazutoshi
    Kawabata, Shinji
    Ikeda, Shinya
    Sugawara, Masayuki
    BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH, 2024, 43 (03) : 250 - 259
  • [34] Estimating degradation in real time and accelerated stability tests with random lot-to-lot variation: A simulation study
    Magari, RT
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (03) : 893 - 899
  • [35] Lot-to-Lot Variance in Immunoassays-Causes, Consequences, and Solutions
    Luo, Yunyun
    Pehrsson, Martin
    Langholm, Lasse
    Karsdal, Morten
    Bay-Jensen, Anne-Christine
    Sun, Shu
    DIAGNOSTICS, 2023, 13 (11)
  • [36] LOT-TO-LOT VARIABILITY OF 2 RHEUMATOID-FACTOR TESTS
    KILBOURN, JP
    JOURNAL OF THE AMERICAN MEDICAL TECHNOLOGISTS, 1977, 39 (05): : 237 - 238
  • [37] Evaluation of the Clinical and Laboratory Standards Institute EP26-A Guideline: A Protocol for Reagent Lot-to-Lot Verification
    Katzman, Brooke M.
    Ness, Karl M.
    Algeciras-Schimnich, Alicia
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 : A28 - A28
  • [38] Performance evaluation and lot-to-lot consistency of the Abbott Architects® Progesterone assay
    Rufo, G
    Brookhart, P
    Barnes, W
    Frels, M
    Sheu, M
    White, M
    Chan, S
    Lauren, L
    McHale, P
    Bartko, K
    CLINICA CHIMICA ACTA, 2005, 355 : S271 - S272
  • [39] Estimating Drug Shelf-life with Unknown Lot-to-lot Variability
    Srimaneekarn, N.
    Kiatsupaibul, S.
    Hayter, A. J.
    Liu, W.
    COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION, 2015, 44 (08) : 2195 - 2207
  • [40] The contribution of lot-to-lot variation to the measurement uncertainty of an LC-MS-based multi-mycotoxin assay
    David Stadler
    Michael Sulyok
    Rainer Schuhmacher
    Franz Berthiller
    Rudolf Krska
    Analytical and Bioanalytical Chemistry, 2018, 410 : 4409 - 4418